5-MeO-DMT Benzoate Dosing With Digital Patient Feedback
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing treatments with 5-MeO-DMT are influenced by patient mood and environment, leading to variable outcomes, necessitating improved methods and compositions for optimized patient treatment.
Innovation Solution
A prescription digital therapeutic (PDT) using 5-MeO-DMT benzoate, which involves administering the compound, monitoring patient interaction, assessing response, and adjusting dosage based on interaction data, combined with formulations in various dosage forms and particle sizes to enhance delivery.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If 5-MeO-DMT is administered without monitoring and personalization, then treatment can be simplified and easier to administer, but treatment outcomes become variable and less reliable due to patient mood and environmental factors
Solution Approach 1:
The system performs preliminary assessment of patient readiness, mood, and environmental factors before 5-MeO-DMT administration. This pre-treatment evaluation includes digital questionnaires and biomarker monitoring to determine optimal timing and dosage, ensuring patients are in a suitable state for treatment before the compound is administered.
Solution Approach 2:
The system continuously monitors patient responses during and after 5-MeO-DMT administration through digital interactions, biomarker analysis, and symptom tracking. This real-time feedback enables dynamic adjustment of treatment parameters and provides data for optimizing future dosing decisions, thereby improving treatment reliability.
2Reliability
If dosage is standardized without personalization, then administration becomes simpler and more consistent, but treatment efficacy decreases due to individual patient variability
Solution Approach 1:
The system transitions from static standardized dosing to dynamic personalized dosing. Dosage recommendations are continuously adjusted based on real-time patient data including mood assessments, biomarker levels, treatment response metrics, and environmental factors. This dynamic approach allows optimization of dosage for each individual patient while maintaining systematic control.
Solution Approach 2:
The system modifies multiple treatment parameters including dosage amount, administration frequency, and timing based on individual patient characteristics and real-time monitoring data. Parameters such as 5-MeO-DMT dose (0.2-2.0 mg), administration route, and scheduling are customized for each patient to maximize efficacy while accounting for individual variability.
3Reliability
If treatment monitoring is implemented, then treatment outcomes can be optimized and personalized, but the complexity of treatment administration increases
Solution Approach 1:
The monitoring system integrates multiple functions into a unified digital platform that combines pre-treatment assessment, real-time monitoring during administration, post-treatment follow-up, and data analysis. This multi-functional system handles diverse monitoring tasks including mood tracking, biomarker analysis, symptom monitoring, and dosage recommendation generation through a single integrated interface.
Solution Approach 2:
The system enables patients to actively participate in their own monitoring through self-reported digital questionnaires, mobile app interactions, and at-home biomarker testing. Patients input their own data regarding mood, symptoms, and experiences, reducing the burden on healthcare providers while ensuring continuous monitoring and data collection.
Data Source
AI summary
A method of synthesizing the benzoate salt of 5-MeO-DMT comprising the step of treating the hydrochloride salt of 5-MeO-DMT with a base, prior to the addition of benzoic acid.